CN202562927U - Dynamic blood sugar monitoring system - Google Patents
Dynamic blood sugar monitoring system Download PDFInfo
- Publication number
- CN202562927U CN202562927U CN2012201227625U CN201220122762U CN202562927U CN 202562927 U CN202562927 U CN 202562927U CN 2012201227625 U CN2012201227625 U CN 2012201227625U CN 201220122762 U CN201220122762 U CN 201220122762U CN 202562927 U CN202562927 U CN 202562927U
- Authority
- CN
- China
- Prior art keywords
- blood
- blood sugar
- finger
- monitoring system
- dynamic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
The utility model provides a dynamic blood sugar monitoring system, which comprises a glucose sensor, a blood sugar recorder connected with the glucose sensor, and a finger blood testing strip, wherein the glucose recorder comprises a finger blood signal processing module and a finger blood testing port connected with the finger blood signal processing module, and the finger blood testing strip is operably inserted into the finger blood testing port. An instant current signal I (t) generated by the dynamic blood sugar monitoring system provided by the utility model transmitted to the blood sugar recorder through the glucose sensor, and the blood sugar recorder automatically corrects instant current signal I (t) by means of the finger blood testing strip and converts the instant finger blood testing strip into glucose concentration IG (t). The correction is finished in the testing process without additionally arranging a fingertip blood sugar tester, the steps of artificially inputting a correction value BG (t) to the blood sugar recorder in the correction process, and the like are saved, and therefore delay error and artificial operation error between the instant current signal I (t) and the correction value BG (t) are avoided.
Description
Technical field
The utility model relates to medical instruments field, especially, relates to a kind of dynamic blood glucose monitoring system that can effectively reduce correction error.
Background technology
Existing dynamic blood glucose monitoring system (CGMS) partly is made up of glucose sensor, blood sugar recording device and analysis of blood sugar software etc.Wherein, sensor is implanted subcutaneous and is produced electric signal with glucose generation chemical reaction in the hypodermis interstitial fluid.Electric signal is accepted and stored to the blood sugar recording device; The examinate wears the blood sugar recording device; Import 1～4 finger tip blood glucose value during this time every day and come as a reference sensor is proofreaied and correct, through proofreading and correct the electric signal of accepting in the blood sugar recording device is converted into blood glucose value, and shows through the liquid crystal display in the blood sugar recording device; After test in continuous several days is accomplished, form examinate's blood sugar collection of illustrative plates again through analysis of blood sugar software.In this system monitoring process, can repeatedly use the finger tip blood glucose value and be worth as a reference.
At present, often adopt the method acquisition examinate's of self-blood sugar monitoring (SMBG) finger tip blood glucose value, promptly outside CGMS equipment, dispose the finger tip blood-sugar detecting instrument of a platform independent again.Yet; The SMBG test of adopting finger tip blood-sugar detecting instrument independently to carry out needs certain hour, test result is input to the instant electric current that also needs among the CGMS among certain hour, finger tip blood glucose value and the CGMS also can produce certain delay error; In addition; The finger tip blood glucose value of SMBG test also may produce operate miss in the process of the blood sugar recording device that is transfused to CGMS.
The utility model content
The utility model purpose is to provide a kind of novel dynamic blood glucose monitoring system, with solve existing C GMS in trimming process since reference value with test value can not be worked in coordination with and occur the technical matters of delay and operate miss easily.
For realizing above-mentioned purpose; An aspect according to the utility model; A kind of dynamic blood glucose monitoring system is provided, the blood sugar recording device that comprise glucose sensor, is connected, and has referred to blood test strip, it is characterized in that with glucose sensor; The blood sugar recording device comprises finger blood signal processing module and the finger blood test port that is connected with finger blood signal processing module, refers to that the exercisable insertion of blood test strip refers in the blood test port.
Further, the blood sugar recording device also comprises blood sugar test port and the dynamic blood sugar signal processing module that is connected with the blood sugar test port, and the blood sugar test port is connected with glucose sensor.
Further, the blood sugar recording device also comprises microprocessor, refers to that the blood signal processing module all is connected with microprocessor with dynamic blood sugar signal processing module.
Further, the blood sugar recording device also comprises display screen and PORT COM, and display screen all is connected with microprocessor with PORT COM.
The utlity model has following beneficial effect: this dynamic blood glucose monitoring system does not need additional configuration finger tip blood glucose monitoring system to accomplish correction; Removed from timing and artificially imported corrected value BG steps such as (t), thereby avoided delay time error and the manual operation error between instant current signal I (t) and the corrected value BG (t) to the blood sugar recording device.
Except top described purpose, feature and advantage, the utility model also has other purpose, feature and advantage.To do further detailed explanation to the utility model with reference to figure below.
Description of drawings
The accompanying drawing that constitutes the application's a part is used to provide the further understanding to the utility model, and illustrative examples of the utility model and explanation thereof are used to explain the utility model, do not constitute the improper qualification to the utility model.In the accompanying drawings:
Fig. 1 is the dynamic blood glucose monitoring system test module synoptic diagram of the utility model preferred embodiment;
Fig. 2 is the blood sugar recording device interior section module diagram of the utility model preferred embodiment;
Fig. 3 is the blood sugar recording device external structure synoptic diagram of the utility model preferred embodiment.
Embodiment
Embodiment to the utility model is elaborated below in conjunction with accompanying drawing, but the multitude of different ways that the utility model can be defined by the claims and cover is implemented.
Referring to Fig. 1, blood sugar recording device 2 and analysis of blood sugar software 3 that the dynamic blood glucose monitoring system of the utility model comprises glucose sensor 1, is connected in order with glucose sensor 1, and the test of the finger blood in the exercisable insertion blood sugar recording of the timing device 2 strip 4.
Referring to Fig. 2, the blood sugar recording device 2 of the utility model comprises and refers to blood signal processing module 21, dynamic blood sugar signal processing module 22 and be connected the microprocessor 23 that refers to blood signal processing module 21 and dynamic blood sugar signal processing module 22.
Referring to Fig. 3, the blood sugar recording device 2 of the utility model also comprises finger blood test port 211 and dynamic blood sugar test port 212.Wherein, dynamically blood sugar test port 212 outsides are connected with glucose sensor 1, and inner and dynamic blood sugar signal processing module 22 is connected; Refer to that blood test port 211 is connected with referring to blood signal processing module 21, timing refers to that the 4 exercisable insertions of blood test strip refer in the blood test port 211.
In the test process, glucose sensor 1 the energising situation under, its probe on glucose oxidase at first with interstitial fluid in glucose react, produce instant current signal I (t).This instant current signal I (t) transfers to dynamic blood sugar test port 212 backs through glucose sensor 1 and is obtained by dynamic blood sugar signal processing module 22, and is stored in the microprocessor 23.At this moment, instant current signal I (t) is not equal to interstitial fluid concentration of glucose IG (t), but the relation that both are directly proportional: IG (t)=I (t)/K.
Generally speaking, the K value can vary with each individual, so for different users, the test value BG (t) that need use self-blood sugar monitoring (SMBG) proofreaies and correct dynamic blood glucose monitoring system; At timing; To refer to that at first 4 insertions of blood test strip refer to blood test port 211, then blood sample dripped on finger blood test strip 4 that the blood bar drips moment; Refer to that blood signal processing module 21 detects blood sample information; Through microprocessor 23 blood sample to be tested is immediately changed out corresponding corrected value BG (t) again, simultaneously, instant current signal I (t) corresponding in the blood sugar recording device 2 is interrelated with the corrected value BG (t) that refers to 4 tests of blood test strip; Obtain the K value, and three's relation satisfies equation: K=I (t)/BG (t).At last; Call the instant current signal I (t) that dynamic subsequently blood sugar signal processing module 22 obtains; According to IG (t)=I (t)/K relational expression, convert current signal I (t) to interstitial fluid concentration of glucose IG (t) again, the IG (t) that obtain this moment is stored in the blood sugar recording device 2.This kind mode need not manually to import corrected value BG (t), also can not have the delay error between BG (t) and the I (t).
Preferably; In dynamic blood glucose monitoring system use; Glucose sensor 1 also can be because of the decline of glucose oxidase activity, the change of monitoring of environmental, the influence of the factors such as change of monitoring matrix; Need to detect a plurality of corrected value BG (t) and come the instant current signal I (t) that obtains is subsequently repeatedly proofreaied and correct, carry out the accuracy of follow-on test to guarantee dynamic blood glucose monitoring system.
Blood sugar recording device 2 also is provided with display screen 24 and PORT COM 25, and display screen 24 all is connected with microprocessor 23 with PORT COM 25.Concentration of glucose IG (t) is stored and is shown through display screen 24 by blood sugar recording device 2.By the time after test data accumulation in continuous several days is accomplished; The test data of accumulation is downloaded in the PC that analysis of blood sugar software 3 is installed through the PORT COM on the blood sugar recording device 2 25; The processing of process analysis of blood sugar software 3 forms examinate's blood sugar collection of illustrative plates, and person under inspection or medical personnel come guiding treatment through this blood sugar collection of illustrative plates.
The dynamic blood glucose monitoring system that the utility model relates to; The instant current signal I (t) of its generation transfers to blood sugar recording device 2 through glucose sensor 1, and blood sugar recording device 2 is by referring to that blood test strip 4 is converted into concentration of glucose IG (t) with instant current signal I (t) after NMO correction.This test process does not need additional configuration finger tip blood glucose monitoring system to accomplish correction; Having removed from timing is input corrected value BG steps such as (t) to blood sugar recording device 2 people, thereby has avoided delay time error and the manual operation error between instant current signal I (t) and the corrected value BG (t).
The preferred embodiment that the above is merely the utility model is not limited to the utility model, and for a person skilled in the art, the utility model can have various changes and variation.All within the spirit and principle of the utility model, any modification of being done, be equal to replacement, improvement etc., all should be included within the protection domain of the utility model.
Claims (4)
1. dynamic blood glucose monitoring system; Comprise: glucose sensor (1), the blood sugar recording device (2) that is connected with said glucose sensor (1), and refer to blood test strip (4); It is characterized in that; Said blood sugar recording device (2) comprises finger blood signal processing module (21) and the finger blood test port (211) that is connected with said finger blood signal processing module (21), in the said finger blood test exercisable insertion of strip (4) the said finger blood test port (211).
2. dynamic blood glucose monitoring system according to claim 1; It is characterized in that; Said blood sugar recording device (2) also comprises blood sugar test port (212) and the dynamic blood sugar signal processing module (22) that is connected with said blood sugar test port (212), and said blood sugar test port (212) is connected with said glucose sensor (1).
3. dynamic blood glucose monitoring system according to claim 2; It is characterized in that; Said blood sugar recording device (2) also comprises microprocessor (23), and said finger blood signal processing module (21) all is connected with said microprocessor (23) with said dynamic blood sugar signal processing module (22).
4. dynamic blood glucose monitoring system according to claim 3 is characterized in that, said blood sugar recording device (2) also comprises display screen (24) and PORT COM (25), and said display screen (24) all is connected with said microprocessor (23) with said PORT COM (25).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012201227625U CN202562927U (en) | 2012-03-28 | 2012-03-28 | Dynamic blood sugar monitoring system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012201227625U CN202562927U (en) | 2012-03-28 | 2012-03-28 | Dynamic blood sugar monitoring system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN202562927U true CN202562927U (en) | 2012-11-28 |
Family
ID=47212572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012201227625U Expired - Fee Related CN202562927U (en) | 2012-03-28 | 2012-03-28 | Dynamic blood sugar monitoring system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN202562927U (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107543899A (en) * | 2016-06-28 | 2018-01-05 | 罗伯特·博世有限公司 | For the method and control device being corrected to the output signal of Abgassensor |
| CN107788994A (en) * | 2017-10-12 | 2018-03-13 | 微泰医疗器械(杭州)有限公司 | A kind of real-time dynamic blood sugar monitoring system of intelligence based on high in the clouds big data and method |
| CN108169466A (en) * | 2012-06-08 | 2018-06-15 | 美敦力迷你迈德公司 | Application of the electrochemical impedance spectroscopy in sensing system, equipment and associated method |
-
2012
- 2012-03-28 CN CN2012201227625U patent/CN202562927U/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108169466A (en) * | 2012-06-08 | 2018-06-15 | 美敦力迷你迈德公司 | Application of the electrochemical impedance spectroscopy in sensing system, equipment and associated method |
| CN108169466B (en) * | 2012-06-08 | 2020-05-05 | 美敦力迷你迈德公司 | Use of electrochemical impedance spectroscopy in sensor systems, devices, and related methods |
| US10660555B2 (en) | 2012-06-08 | 2020-05-26 | Medtronic Minimed, Inc. | Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods |
| US10905365B2 (en) | 2012-06-08 | 2021-02-02 | Medtronic Minimed, Inc. | Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods |
| US11160477B2 (en) | 2012-06-08 | 2021-11-02 | Medtronic Minimed, Inc. | Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods |
| US11234624B2 (en) | 2012-06-08 | 2022-02-01 | Medtronic Minimed, Inc. | Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods |
| CN107543899A (en) * | 2016-06-28 | 2018-01-05 | 罗伯特·博世有限公司 | For the method and control device being corrected to the output signal of Abgassensor |
| CN107788994A (en) * | 2017-10-12 | 2018-03-13 | 微泰医疗器械(杭州)有限公司 | A kind of real-time dynamic blood sugar monitoring system of intelligence based on high in the clouds big data and method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Light et al. | Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2 | |
| Kaufmann et al. | ARTiiFACT: a tool for heart rate artifact processing and heart rate variability analysis | |
| US7815569B2 (en) | Method, system and computer program product for evaluating the accuracy of blood glucose monitoring sensors/devices | |
| RU2749187C2 (en) | Computer-implemented method and portable apparatus for analysis of glucose control data indicating glucose level in bodily fluid | |
| CN108830034B (en) | Medicine clinical research and development information processing system and method | |
| WO2007112034A3 (en) | System and methods for improved diabetes data management and use | |
| Wagner et al. | Continuous glucose monitoring: a review for behavioral researchers | |
| CN102184661A (en) | Childhood autism language training system and internet-of-things-based centralized training center | |
| US20200383645A1 (en) | Method and device for analyzing continuously monitored physiological measurement values of a user | |
| AU2002320094A1 (en) | Integrated blood sampling analysis system with multi-use sampling module | |
| CN104380297B (en) | Data storage method for photoelectric synchronous brain activity recording | |
| ATE550642T1 (en) | METHOD FOR MEASURING 1,5-ANHYDROGLUCITOL IN WHOLE BLOOD | |
| Correia et al. | Validation of a wireless bluetooth photoplethysmography sensor used on the earlobe for monitoring heart rate variability features during a stress-inducing mental task in healthy individuals | |
| CN202562927U (en) | Dynamic blood sugar monitoring system | |
| CN105919556A (en) | Near-infrared brain imager map collecting method based on cognitive tasks | |
| CN1908668A (en) | Portable wireless blood sugar testing instrument and blood sugar horizontal medical monitoring system | |
| CN204765670U (en) | Human blood sugar monitoring analysor of high -risk patient | |
| CN106338596A (en) | Health monitoring method, health monitoring apparatus, and electronic equipment | |
| CN103027669B (en) | For the method and apparatus judging floating and sinking degree of pulse condition | |
| Katz et al. | A comprehensive evaluation of strip performance in multiple blood glucose monitoring systems | |
| Laureys et al. | Unresponsive wakefulness syndrome | |
| CN103405224A (en) | Physiological index detection system for evaluating psychological neural activity | |
| Craven et al. | User requirements for the development of smartphone self-reporting applications in healthcare | |
| CN203408054U (en) | Multi-channel psychological analyzer based on Linux real-time operating system | |
| WO2016061767A1 (en) | Continuous glucose monitoring system and monitoring terminal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: SINOCARE BIOSENSING CO., LTD Free format text: FORMER NAME: CHANGSHA SINOCARE INC. |
|
| CP03 | Change of name, title or address |
Address after: 410205 Hunan province Changsha high tech Development Zone No. 265 Yuan Lu Valley Patentee after: SINOCARE INC. Address before: 410013 Hunan province Changsha torch high tech Zone of Jixian City Road No. 28 Patentee before: Changsha Sinocare Inc. |
|
| CP03 | Change of name, title or address | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121128 Termination date: 20200328 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |